Rivaroxaban in cardiovascular protection - Getting to the heart of the matter
Event:
ESC Congress 2018
Topic:
Cardiovascular Disease in Special Populations
Session type:
Satellite Symposium
Sponsored by Bayer AG
Date:
26 August 2018
Time:
13:00
-
14:00
Session
4 presentations in this session
A holistic approach to cardiovascular protection with rivaroxaban.
Speaker:
Professor A. Kakkar (London, GB)
Managing the clinical challenges of the multimorbid patient with atiral fibrillation.
Speaker:
Doctor J. Cox (Halifax, CA)
Speaker:
Doctor C. Gibson (Boston, US)
Managing the clinical challenges of the patient with atherothrombotic disease.
Speaker:
Professor M. Cowie (London, GB)
Speaker:
Professor R. Welsh (Edmonton, CA)
Closing remarks - Rivaroxaban in cardiovascular protection - Getting to the heart of the matter.
Speaker:
Professor J. Camm (London, GB)
6 speakers from this session
Professor Ajay
Kakkar
Thrombosis Research Institute, London (United Kingdom of Great Britain & Northern Ireland)
7
presentations
0
follower
Doctor Jafna
Cox
Dalhousie University, Halifax (Canada)
6
presentations
0
follower
Doctor C Michael
Gibson
Harvard Medical School, Boston (United States of America)
10
presentations
0
follower
Professor Martin
Cowie
Imperial College London, London (United Kingdom of Great Britain & Northern Ireland)
93
presentations
3
followers
Professor Robert
Welsh
Mazankowski Alberta Heart Institute, Edmonton (Canada)
15
presentations
0
follower
Professor John
Camm
St George's University of London, London (United Kingdom of Great Britain & Northern Ireland)
55
presentations
0
follower
This platform is supported by
